Detalles de la búsqueda
1.
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials.
J Viral Hepat
; 27(11): 1222-1233, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32594612
2.
Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
Br J Clin Pharmacol
; 78(3): 587-98, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24617605
3.
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.
Lancet HIV
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734016
4.
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
J Acquir Immune Defic Syndr
; 91(1): 68-72, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972855
5.
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Hum Vaccin
; 7(12): 1336-42, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22185811
6.
Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA™).
Vaccine
; 39(20): 2764-2771, 2021 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33867215
7.
Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines.
Hum Vaccin Immunother
; 15(2): 426-432, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30431383
8.
Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection.
Hepatol Commun
; 1(8): 757-764, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29404492
9.
Concomitant use of VAQTA with PedvaxHIB and Infanrix in 12 to 17 month old children.
Hum Vaccin Immunother
; 12(2): 503-11, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26308112
10.
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Vaccine
; 32(48): 6521-6, 2014 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25252192
11.
Analysis of safety data in children after receiving two doses of ProQuad® (MMRV).
Vaccine
; 32(52): 7154-60, 2014 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25219563
12.
Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children.
Hum Vaccin Immunother
; 9(8): 1691-7, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23744509
13.
Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
Vaccine
; 29(45): 7942-8, 2011 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-21875633
14.
A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series.
Pediatr Infect Dis J
; 29(10): 972-4, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20724955
Resultados
1 -
14
de 14
1
Próxima >
>>